This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
by Zacks Equity Research
Cabot (CBT) gains on strength in its Reinforcement Materials segment in Q2, offset by weakness in Performance Chemicals.
Cabot (CBT) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 3.91% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Q1 Earnings Beat Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 25% and 1.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC (FMC) Beats Q1 Earnings Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 2.31% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Buys Solar Farm in Japan, Spurs Sustainability Goals
by Zacks Equity Research
The Chiba solar farm acquired by Cabot (CBT) generates up to 3,500 megawatt-hours (MWh) of electricity per year, powering approximately 700 Japanese houses per year.
Cabot (CBT) Unveils Technology Platform for Reinforcing Carbons
by Zacks Equity Research
Cabot's (CBT) EVOLVE Sustainable Solutions technology platform is aimed at boosting the development of sustainable reinforcing carbons.
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot are part of the Zacks Industry Outlook article.
4 Diversified Chemical Stocks to Escape Industry Challenges
by Anindya Barman
Demand worries due to weakness in certain markets and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, ALB and CBT are poised to navigate the industry challenges.
Cabot (CBT) to Unveil Battey Application Center in Europe
by Zacks Equity Research
The new technology center will allow Cabot (CBT) to enhance its battery materials development capabilities.
Cabot's (CBT) Earnings and Revenues Outshine Estimates in Q1
by Zacks Equity Research
Cabot's (CBT) Q1 performance reflects a decline in volumes due to consumer destocking and COVID-19 outbreaks in China. Weak demand and unfavorable currency movements also played a role.
Cabot (CBT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 2.08% and 11.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) to Boost CCA Capacity to Support EV Transition
by Zacks Equity Research
Cabot's (CBT) investment in Carbon additives is expected to solidify its position as a leading producer of CCAs for lithium-ion battery applications.
Why Is Cabot (CBT) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
Cabot's (CBT) results were aided by higher margins and stronger volumes in the fiscal fourth quarter.
Cabot (CBT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 4.73% and 7.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Matches Q3 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 0% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Kronos Worldwide (KRO) delivered earnings and revenue surprises of -51.35% and 10.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Univar (UNVR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Univar (UNVR) delivered earnings and revenue surprises of 12% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot's (CBT) Shares Up 17% YTD: What's Driving the Stock?
by Zacks Equity Research
Cabot (CBT) gains on strong underlying demand across its businesses, its disciplined execution of operations and strategic acquisition.
5 Top-Notch Dividend Plays in the Diversified Chemical Industry
by Anindya Barman
Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.
Cabot (CBT) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Solid fiscal third quarter results and upbeat outlook have contributed to the run-up in Cabot's (CBT) shares.
Pan American Silver (PAAS) Q2 Earnings & Sales Miss Estimates
by Zacks Equity Research
Pan American Silver (PAAS) reports a loss for Q2 due to lower silver prices. Management maintains silver production guidance between 19 million ounces and 20.5 million ounces for 2022.
Franco-Nevada (FNV) Q2 Earnings & Sales Beat Estimates, Up Y/Y
by Zacks Equity Research
Franco-Nevada's (FNV) Q2 top-line results benefit from higher realized oil and gas prices.